NanoViricides
NNVC
#10061
Rank
โ‚น2.30 B
Marketcap
โ‚น106.91
Share price
1.94%
Change (1 day)
-6.10%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น52.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น56.62. an increase over its 2024 EPS that were of -โ‚น64.97.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025-โ‚น58.47-10%
2024-โ‚น64.97-5.41%
2023-โ‚น68.685.71%
2022-โ‚น64.97-13.58%
2021-โ‚น75.18-66.11%
2020-โ‚น221.821.7%
2019-โ‚น218.11-10.98%
2018-โ‚น245.03-22.35%
2017-โ‚น315.56-10.53%
2016-โ‚น352.69375%
2015-โ‚น74.25-85.19%
2014-โ‚น501.1942.11%
2013-โ‚น352.6926.67%
2012-โ‚น278.44-6.25%
2011-โ‚น297.0014.28%
2010-โ‚น259.88100%
2009-โ‚น129.94-0%
2008-โ‚น129.94-33.33%
2007-โ‚น194.91-0%
2006-โ‚น194.914445.07%
2005-โ‚น4.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
โ‚น605.14-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น678.16-1,297.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น275.65-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น349.72-717.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น196.76-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.64-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA